Project Aim
The aim of this project was to investigate the impact of gene therapy for Leber Congenital Amaurosis (LCA) using a dog model of the disease.
Project Results and Impact
Following gene therapy, the vision impaired dogs showed remarkable improvement in their sight. After this success, the team focused its attention on Age Related Macular Degeneration (AMD).
Professor Rakoczy and her team developed a promising approach called Secretion Gene Therapy to treat wet AMD. Their preclinical trials have shown positive results in inhibiting the growth of harmful blood vessels and maintaining vision. They are now seeking approval to conduct human trials in Australia, with the aim of starting clinical trials soon.
Chief investigator:
Professor Elizabeth Rakoczy
Research at Lions Eye Institute, University of Western Australia
Grant awarded:
$60,000 (2007)
Research Impact Reports
Improving real-world mobility and assessing long-term safety outcomes with a retinal prosthesis (“Bionic Eye”)
Project Aim This project aimed to measure visual outcomes of...
RNA base editing strategies as potential therapeutic of inherited retinal dystrophies
Project Aim This study aimed to use a new genetic...
Neuroprotective effect of SAHA in Retinitis Pigmentosa. Do time and frequency matter?
Project Aim Retinitis Pigmentosa (RP) is a genetic, blinding retinal...
Read more about Improving Sensory Substitution Low Vision Devices Through Novel Software Adaptations
Improving Sensory Substitution Low Vision Devices Through Novel Software Adaptations
Project Aim To investigate the efficacy of sensory substitution devices...